Alberta Investment Management Corp (AIMCo)’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-262,574
Closed -$7.77M 1063
2023
Q4
$7.77M Buy
262,574
+20,996
+9% +$436K 0.07% 184
2023
Q3
$5.02M Buy
241,578
+52,329
+28% +$1.44M 0.05% 271
2023
Q2
$4.64M Buy
+189,249
New +$6.09M 0.04% 339
2019
Q4
Sell
-8,100
Closed -$478K 1008
2019
Q3
$478K Hold
8,100
﹤0.01% 760
2019
Q2
$523K Hold
8,100
﹤0.01% 758
2019
Q1
$514K Buy
+8,100
New +$425K ﹤0.01% 750

Other funds holding TNDM

Alberta Investment Management Corp (AIMCo)'s TNDM Position: Q1 2024 in Review

Alberta Investment Management Corp (AIMCo) sold out of Tandem Diabetes Care (TNDM) in Q1 2024, closing a stake of 262,574 shares — an estimated $7.77M sold.

Alberta Investment Management Corp (AIMCo) first reported a position in TNDM in Q1 2019 and held it in 6 quarters. The position peaked at $7.77M in Q4 2023. 291 funds tracked by Wall St. Rank hold TNDM as of Q1 2024.

  • Alberta Investment Management Corp (AIMCo) reported no remaining Tandem Diabetes Care position as of Q1 2024 after selling out during the quarter.
  • Alberta Investment Management Corp (AIMCo) sold 262,574 Tandem Diabetes Care shares in Q1 2024, an estimated $7.77M.
  • Alberta Investment Management Corp (AIMCo) first reported a position in Tandem Diabetes Care in Q1 2019 and held it in 6 quarters.
  • Alberta Investment Management Corp (AIMCo)'s Tandem Diabetes Care position peaked at $7.77M in Q4 2023.
  • 291 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2024.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q1 2024, filed 15 May 2024.